Carregant...
More Haste, Less Speed: Could Public–Private Partnerships Advance Cellular Immunotherapies?
Cellular immunotherapies promise to transform cancer care. However, they must overcome serious challenges, including: (1) the need to identify and characterize novel cancer antigens to expand the range of therapeutic targets; (2) the need to develop strategies to minimize serious adverse events, suc...
Guardat en:
| Publicat a: | Front Med (Lausanne) |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5561330/ https://ncbi.nlm.nih.gov/pubmed/28861415 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2017.00134 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|